Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name | LipidBank ID | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula ▼ |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AV03 |
|
44261142 | 1794.002652 | C84H151N3O37 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CI03 |
|
44261454 | 1794.002652 | C84H151N3O37 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CK03 |
|
44261470 | 1794.002652 | C84H151N3O37 | |||
Neutral glycosphingolipids | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) | LMSP0506BJ03 |
|
44261702 | 1794.002652 | C84H151N3O37 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AH03 |
|
44260670 | 1778.007737 | C84H151N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS03 |
|
44260758 | 1778.007737 | C84H151N3O36 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BM03 |
|
44261278 | 1778.007737 | C84H151N3O36 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CN03 |
|
44261486 | 1778.007737 | C84H151N3O36 | |||
Neutral glycosphingolipids | Galalpha1-4Galbeta1-4Glc- (Globo series) | LMSP0502AF08 |
|
44260211 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galalpha1-4Galbeta1-4Glc- (Globo series) | LMSP0502BE08 |
|
44260411 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galalpha1-4Galbeta1-4Glc- (Globo series) | LMSP0502BG08 |
|
44260427 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galalpha1-4Galbeta1-4Glc- (Globo series) | LMSP0502BL08 |
|
44260467 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) | LMSP0503AD08 |
|
44260515 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) | LMSP0503AF08 |
|
44260531 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) | LMSP0503AM08 |
|
44260587 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AL08 |
|
44260707 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504BR08 |
|
44260955 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505AL08 |
|
44261067 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505BG08 |
|
44261235 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CB08 |
|
44261403 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505CF08 |
|
44261435 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EJ08 |
|
44261811 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) | LMSP0505EL08 |
|
44261819 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) | LMSP0506AK08 |
|
44261899 | 1730.022992 | C84H151N3O33 | |||
Neutral glycosphingolipids | Galalpha1-3Galbeta1-4Glc- (Isoglobo series) | LMSP0506AM08 |
|
44261915 | 1730.022992 | C84H151N3O33 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024